- Home
- MNDO vs AYTU Comparison
MNDO vs AYTU Comparison
Compare MNDO & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- AYTU
- Stock Information
- Founded
- MNDO 1995
- AYTU N/A
- Country
- MNDO Israel
- AYTU United States
- Employees
- MNDO N/A
- AYTU N/A
- Industry
- MNDO EDP Services
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- MNDO Technology
- AYTU Health Care
- Exchange
- MNDO Nasdaq
- AYTU Nasdaq
- Market Cap
- MNDO 24.4M
- AYTU 23.0M
- IPO Year
- MNDO 2000
- AYTU N/A
- Fundamental
- Price
- MNDO $1.08
- AYTU $2.29
- Analyst Decision
- MNDO
- AYTU Strong Buy
- Analyst Count
- MNDO 0
- AYTU 3
- Target Price
- MNDO N/A
- AYTU $9.17
- AVG Volume (30 Days)
- MNDO 43.8K
- AYTU 242.9K
- Earning Date
- MNDO 11-07-2025
- AYTU 11-12-2025
- Dividend Yield
- MNDO 20.56%
- AYTU N/A
- EPS Growth
- MNDO N/A
- AYTU N/A
- EPS
- MNDO 0.15
- AYTU N/A
- Revenue
- MNDO $20,155,000.00
- AYTU $66,382,000.00
- Revenue This Year
- MNDO N/A
- AYTU N/A
- Revenue Next Year
- MNDO N/A
- AYTU $19.03
- P/E Ratio
- MNDO $7.13
- AYTU N/A
- Revenue Growth
- MNDO N/A
- AYTU 1.84
- 52 Week Low
- MNDO $0.98
- AYTU $0.95
- 52 Week High
- MNDO $2.13
- AYTU $2.82
- Technical
- Relative Strength Index (RSI)
- MNDO 43.85
- AYTU 51.39
- Support Level
- MNDO $0.98
- AYTU $2.23
- Resistance Level
- MNDO $1.10
- AYTU $2.42
- Average True Range (ATR)
- MNDO 0.04
- AYTU 0.15
- MACD
- MNDO 0.00
- AYTU 0.01
- Stochastic Oscillator
- MNDO 62.48
- AYTU 53.23
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.